Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.532 USD
0.4%
Updated:
May 13, 2024
Atara Biotherapeutics Inc
Net Issuance of Common Stock
|
Atara Biotherapeutics Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Net Issuance of Common Stock
$2.1m
|
CAGR 3-Years
-83%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.8B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$768m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$293m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Atara Biotherapeutics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
2.1m
USD
2.1m
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Net Issuance of Common Stock amounts to 2.1m USD.
What is Atara Biotherapeutics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-64%
-64%
Over the last year, the Net Issuance of Common Stock growth was -90%. The average annual Net Issuance of Common Stock growth rates for Atara Biotherapeutics Inc have been -83% over the past three years , -64% over the past five years .
You don't have any saved screeners yet
